MRIMath

medical devices

About

MRIMath is a medical technology company based in Birmingham, Alabama, founded in 2017. The company specializes in artificial intelligence solutions for brain tumor analysis, focusing on glioblastoma segmentation and volumetric measurement. Their flagship product, MRIMath i2Contour, is an FDA-cleared tool that enhances the efficiency and accuracy of brain tumor mapping and measurement. This platform allows physicians to perform tumor and organs-at-risk segmentation and volumetric analysis quickly and accurately through a secure cloud-based system. MRIMath aims to improve medical decision-making by providing reliable AI and machine learning tools that enhance patient outcomes and physician satisfaction. The company values innovation, customer focus, and high standards, creating a supportive workplace environment. Their primary customers include neuro-oncologists, radiologists, and other medical professionals involved in brain tumor diagnosis and treatment, with endorsements from leading institutions highlighting the platform's accuracy and usability.

Technologies

Rackspace MailGun Gmail Google Apps Mobile Friendly Google Font API Google Tag Manager reCAPTCHA AddThis ShareThis Bootstrap Framework AI Remote

Keywords

hospital care medical device medical & health medical equipment manufacturing data security medical equipment and supplies manufacturing brain mri segmentation ai in radiology automated volumetric analysis cloud collaboration bayesian ai model cloud-based medical imaging neuro-radiology ai dicom viewer medical software automated contouring neuro-oncology medical devices neuro-oncology solutions organ at risk segmentation healthcare analytics metastatic brain tumor clinical workflow integration medical imaging software b2b longitudinal tumor analysis volumetric measurements ai-powered segmentation uncertainty quantification ai ai segmentation

Location

Birmingham, Alabama, United States

Related Companies

Companies in the same industry